Fulvio Mavilio, PhD - "Four years at Genethon: perspectives and problems for gene therapy of blood and muscle diseases"
Jun 22, 2016
from 12:00 AM to 01:00 PM
|Where||Tigem Auditorium "Vesuvius"|
|Contact Name||Diez Roux|
|Add event to calendar||
Fulvio Mavilio, Ph.D., is Scientific Director of Genethon (Evry, France), and Professor of Molecular Biology and University of Modena and Reggio Emilia (Modena, Italy). He was Director of Discovery of Molmed S.p.A. (2002-2005) and founder and Chief Scientific Officer of Genera S.p.A. (1999-2002), two biotechnology companies in Milan. He had previously served as co-Director of the San Raffaele-Telethon Institute of Gene Therapy in Milan (1995 to 2002), as director of the Molecular Hematology unit of the San Raffaele Institute (1989 to 1995), as Visiting Scientist at the Wistar Institute, Philadelphia, (1986 to 1988), as group leader in the Department of Hematology-Oncology of an the Istituto Superiore di Sanità, a government authority in Rome (1984 to 1988), and as staff scientist of the Institute of Experimental Medicine of the Italian National Research Council in Rome (1982 to 1984). Prof. Mavilio is member of the European Molecular Biology Association (EMBO), Chairman of the Educational Committee of the American Society of Gene Therapy (ASGT), and member of the Editorial Board of many international journals in the fields of genetics, molecular biology and gene therapy. He graduated in Biology at the University of Rome in 1976, and obtained a Ph.D. in Medical Genetics at the School of Medicine of the same University in 1979. He was awarded a Special Fellowship by the Italian National Research Council, Rome (1978-1982), and a U.S. Public Health Service International Research Fellowship by the Fogarty International Center, NIH, Bethesda (1986-1988). Prof. Mavilio is an expert and a pioneer in the fields of gene therapy and stem cell research, and author of over 140 articles in major international journals. He was born in Naples in 1953.